Related Experiment Video
Updated: Apr 1, 2026
14:49
Conducting Respiratory Oscillometry in an Outpatient Setting
Published on: April 8, 2022
8.9K
Vascular Biomarkers in Asthma and COPD
Petros Bakakos1, George Patentalakis, Alberto Papi
111 Kononos St, Athens 11634, Greece. petros44@hotmail.com.
Current Topics in Medicinal Chemistry
|October 1, 2015
Summary
Bronchial asthma and chronic obstructive pulmonary disease involve airway microvascular changes. This review explores vascular biomarkers and therapeutic implications for these chronic respiratory diseases.
Area of Science:
- Pulmonary Medicine
- Vascular Biology
- Respiratory Diseases
Background:
- Bronchial asthma and COPD are major global health issues.
- Airway microvascular changes contribute to airway remodeling in both conditions.
- Vascular endothelial growth factor (VEGF) plays a key role in airway vascular remodeling.
Purpose of the Study:
- To review current knowledge on vascular biomarkers in asthma and COPD.
- To explore the therapeutic implications of targeting vascular mediators.
- To elucidate the role of microvascular changes in disease progression.
Main Methods:
- Literature review of studies on airway microvasculature in asthma and COPD.
- Analysis of the role of various cells and mediators in vascular remodeling.
- Examination of the effects of anti-asthma drugs on airway microvasculature.
Main Results:
- Angiogenesis is more prevalent in asthma, while vasodilation is more relevant in COPD.
- Vascular leak is present in both asthma and COPD.
- VEGF promotes endothelial cell proliferation, vascular leakage, and inflammatory responses in asthma.
Conclusions:
- Vascular biomarkers offer potential therapeutic targets for asthma and COPD.
- Further research is needed to understand the impact of COPD drugs on the airway microvascular network.
- Targeting vascular components may be a promising strategy for managing chronic airway inflammation.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
4.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.9K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.4K
01:20Asthma: Pathogenesis and Management
1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
01:30Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
767
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
767
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.1K